• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Cooperstone Elliot sold $285,458 worth of shares (75,000 units at $3.81) (SEC Form 4)

    1/9/24 9:32:26 PM ET
    $CANO
    Medical/Nursing Services
    Health Care
    Get the next $CANO alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Cooperstone Elliot

    (Last) (First) (Middle)
    C/O ITC RUMBA, LLC
    ONE VANDERBILT AVE., 24TH FLOOR

    (Street)
    NEW YORK NY 10017

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Cano Health, Inc. [ CANO ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    01/05/2024
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    Form filed by One Reporting Person
    X Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Class A Common Stock 01/05/2024 S 25,000 D $3.8493(1) 124,171 I See Footnote(2)
    Class A Common Stock 01/08/2024 S 25,000 D $3.8221(3) 99,171 I See Footnote(2)
    Class A Common Stock 01/09/2024 S 25,000 D $3.7469(4) 74,171 I See Footnote(2)
    Class A Common Stock 148 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    1. Name and Address of Reporting Person*
    Cooperstone Elliot

    (Last) (First) (Middle)
    C/O ITC RUMBA, LLC
    ONE VANDERBILT AVE., 24TH FLOOR

    (Street)
    NEW YORK NY 10017

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    ITC Rumba, LLC

    (Last) (First) (Middle)
    ONE VANDERBILT AVE., 24TH FLOOR

    (Street)
    NEW YORK NY 10017

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    Explanation of Responses:
    1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.62 to $4.04. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1, 3 and 4 to this Form 4.
    2. These securities are owned directly by ITC Rumba, LLC ("ITC Rumba"), a ten percent owner of the Issuer. Elliot Cooperstone is the Founder and Managing Partner of ITC Rumba and therefore may be deemed the beneficial owner of these securities.
    3. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.65 to $4.04.
    4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.585 to $3.90.
    /s/ Elliot Cooperstone 01/09/2024
    /s/ Elliot Cooperstone, Managing Partner of ITC Rumba, LLC 01/09/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $CANO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CANO

    DatePrice TargetRatingAnalyst
    8/11/2023Buy → Hold
    Jefferies
    8/11/2023$4.00 → $0.80Buy → Neutral
    Citigroup
    1/6/2023$12.00 → $1.25Buy → Neutral
    UBS
    1/5/2023Outperform → Peer Perform
    Wolfe Research
    12/13/2022$1.50Underperform
    BofA Securities
    11/10/2022$10.00 → $3.00Outperform → Market Perform
    Cowen
    11/10/2022Outperform → Mkt Perform
    Raymond James
    10/27/2022$10.00 → $5.00Outperform → Neutral
    Credit Suisse
    More analyst ratings

    $CANO
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Cano Health Announces Agreement with Unsecured Creditors Committee and Court Approval of Disclosure Statement for its Reorganization Plan

      Emergence from Chapter 11 Expected in Third Quarter of 2024 MIAMI, May 21, 2024 /PRNewswire/ -- Cano Health, Inc. (NYSE: CANO) ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today announced a global agreement with the Unsecured Creditors Committee representing the interests of the Company's general unsecured creditors, with the support of the Ad Hoc Lender Group. It also received approval of its Disclosure Statement by the U.S. Bankruptcy Court for the District of Delaware (the "Court"), paving the way to solicit creditor approval of its Plan of Reorganization and its expected emergence from Chapter 11 in the third quarter. Mark

      5/21/24 5:04:00 PM ET
      $CANO
      Medical/Nursing Services
      Health Care
    • NYSE Suspends Trading in Cano Health, Inc. (CANO) and Commences Delisting Proceedings

      MIAMI, Feb. 5, 2024 /PRNewswire/ -- Cano Health, Inc. (NYSE:CANO) ("Cano Health" or the "Company") announced today that on February 5, 2024, the New York Stock Exchange (the "NYSE") notified the Company that the NYSE had determined to (a) commence proceedings to delist the Company's Class A common stock, par value $0.01 per share ("Common Stock") and (b) immediately suspend trading in the Company's Common Stock pursuant to Section 802.01D of the NYSE Listed Company Manual after the Company filed voluntary petitions for relief under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware on February 4, 2024.

      2/5/24 4:35:00 PM ET
      $CANO
      Medical/Nursing Services
      Health Care
    • Cano Health Enters Restructuring Support Agreement with a Significant Majority of its Lenders to Strengthen Financial Position

      Positions the Company to Advance Its Ongoing Transformation Plan Designed to Significantly Reduce Costs, Enhance Productivity, and Improve Cash Flow Receives Commitment for $150 Million in New Capital Ensures Patients Continue to Receive High-Quality Care Across Medical Centers MIAMI, Feb. 4, 2024 /PRNewswire/ -- Cano Health, Inc. (NYSE:CANO) ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today announced that it has entered into a Restructuring Support Agreement (the "RSA") with lenders (the "Ad Hoc Lender Group") holding approximately 86% of its secured revolving and term loan debt and 92% of its senior unsecured notes. This a

      2/4/24 11:57:00 PM ET
      $CANO
      Medical/Nursing Services
      Health Care

    $CANO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Cano Health downgraded by Jefferies

      Jefferies downgraded Cano Health from Buy to Hold

      8/11/23 10:23:10 AM ET
      $CANO
      Medical/Nursing Services
      Health Care
    • Cano Health downgraded by Citigroup with a new price target

      Citigroup downgraded Cano Health from Buy to Neutral and set a new price target of $0.80 from $4.00 previously

      8/11/23 7:12:10 AM ET
      $CANO
      Medical/Nursing Services
      Health Care
    • Cano Health downgraded by UBS with a new price target

      UBS downgraded Cano Health from Buy to Neutral and set a new price target of $1.25 from $12.00 previously

      1/6/23 8:53:28 AM ET
      $CANO
      Medical/Nursing Services
      Health Care